Back
Compare AU
Compare GDX vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Gold Miners ETF (GDX) and the Betashares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
GDX | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 284 | 72 |
Median incremental investment | $1,092.75 | $742.79 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,692.00 | $2,026.35 |
Average age group | > 35 | > 35 |
Key Summary
GDX | DRUG | |
|---|---|---|
Strategy | GDX.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on materials equity. To achieve this investment objective, GDX.AX employs a passive management strategy of investing in the NYSE-listed GDX.AX issued and operated by VanEck in the United States. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Newmont Corp (12.34 %) Agnico Eagle Mines Ltd (8.85 %) Barrick Mining Corp (7.54 %) | AUD - AUSTRALIA DOLLAR (0 %) BRL - BRAZILIAN REAL (0 %) CHF - SWISS FRANC (0 %) |
Top 3 industries | Materials (76.97 %) Other (23.03 %) | Other (75.91 %) Communication Services (33.53 %) Health Care (23.80 %) |
Top 3 countries | Canada (54.95 %) United States (15.85 %) South Africa (11.24 %) | United States (69.91 %) Switzerland (10.93 %) United Kingdom of Great Britain and Northern Ireland (7.38 %) |
Management fee | 0.53 % | 0.57 % |
Key Summary
GDX | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | NYSE Arca Gold Miners Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.53 % | 0.57 % |
Price | $94.00 | $8.55 |
Size | $1.105 billion | $209.051 million |
10Y return | 146.40 % | N/A |
Annual distribution yield (5Y) | 5.00 % | 1.82 % |
Market | ASX | ASX |
First listed date | 26/06/2015 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
GDX | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 284 | 72 |
Median incremental investment | $1,092.75 | $742.79 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,692.00 | $2,026.35 |
Average age group | > 35 | > 35 |
Pros and Cons
GDX | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
GDX | DRUG |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |